Therakind
Therakind is a pharmaceutical company that focuses on the design, development, and commercialization of medicines, particularly in the area of nasal drug delivery. They create formulations aimed at improving patient adherence and enhancing therapeutic outcomes.
- DriDose® Unit Dose
- DriDose® Multi-dose Nozzle
- DriDose® Multi-dose Cartridge
- Oromucosal Midazolam for seizures
- Jylamvo® oral methotrexate solution
- Diamorphine nasal spray for pain management
Locations
Digital Popularity
Social Media
Company Details
Therakind is operated by Therakind Limited and is a Active company incorporated on 14 July 2006 with the registered office located in London, Greater London. Therakind Limited was registered 19 years ago.
Status
Active
Size
Unreported
Directors
4
Age
19 years old
Employees
19
Turnover
Unreported
Total Assets
£13.23M
Cash in Bank
£4.26M
Total Liabilities
-£1.86M
Teams
8
4
3
2
1
Chief Financial Officer • Joined Mar 2024
Pharmceutical Development Director
Postgraduate Research Associate • Joined Dec 2021
Project Assistant • Joined Jan 2015
Responsible Person • Joined Jun 2022
Regulatory Affairs And Pharmacovigilance • Joined Feb 2020
Project Scientist • Joined Mar 2023
Scientist - Research And Logistics • Joined Sep 2023
Chief Financial Officer • Joined Mar 2024
Pharmceutical Development Director
Project Assistant • Joined Jan 2015
Project Scientist • Joined Mar 2023
Postgraduate Research Associate • Joined Dec 2021
Project Scientist • Joined Mar 2023
Scientist - Research And Logistics • Joined Sep 2023
Responsible Person • Joined Jun 2022
Scientist - Research And Logistics • Joined Sep 2023
Regulatory Affairs And Pharmacovigilance • Joined Feb 2020